Sequella Inks $50M Licensing Deal for Tuberculosis Drug

Powerful multidrug cocktails are critically important for battling multidrug-resistant tuberculosis (TB). Industry is working hard to develop new drugs that will not only work well individually, but synergistically, creating an effect where the whole is more than the sum of the parts.